KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
about
Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignanciesKallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft modelThree dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.CXCL12 expression by healthy and malignant ovarian epithelial cells.Functional role of kallikrein 6 in regulating immune cell survival.Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patientsCorrelation of hK6 expression with tumor recurrence and prognosis in advanced gastric cancerIdentification of human tissue kallikrein 6 as a potential marker of laryngeal cancer based on the relevant secretory/releasing protein database.Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6).Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.Potential nanotechnologies and molecular targets in the quest for efficient chemotherapy in ovarian cancer.Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells.Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer.The kallikrein-related peptidase 13 (KLK13) gene is substantially up-regulated after exposure of gastric cancer cells to antineoplastic agents.Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer.Kallikrein-related peptidase-6 (KLK6) mRNA expression is an independent prognostic tissue biomarker of poor disease-free and overall survival in colorectal adenocarcinoma.Clinical relevance of kallikrein-related peptidase 6 (KLK6) and 8 (KLK8) mRNA expression in advanced serous ovarian cancer.Downregulated KLK13 expression in bladder cancer highlights tumor aggressiveness and unfavorable patients' prognosis.
P2860
Q27007065-88102E94-3E98-400A-AD1F-AAC6CB9E333DQ28742738-8EC86063-09E3-4C6F-8845-C10CCD65136BQ33794911-533A4332-AE63-4B6B-9ECA-19C783013C4DQ33848551-8ACB71F3-E0AC-4650-A5D7-6ADAC3F3B41AQ33862447-B8BB6C8D-ED6B-4BA0-B92B-A2164BD57B78Q34738849-6C41D237-92FB-434B-8DAB-3C3500B48AF6Q35032994-91E65CAC-008E-43CA-A238-488B2D6FA773Q35623800-1EF378B5-2BF0-4FD5-89D4-C0BE9F18B49CQ36908718-CCF05AAA-9382-4FB3-97A4-AF2E2BC5B402Q37616960-C57E91B3-A906-4B9F-B221-D6AE1E300D6EQ37690308-7D70BBF7-E006-45B8-89A4-BA5B6FAB3041Q37709144-7633B6F3-3861-4CD6-8E1B-8AD529140BEAQ37952006-B2526BA3-BA20-4506-BFA2-6C07B4DF014AQ38184632-67DDAC50-E856-40BB-91CF-8366BCC0EC57Q38258602-C91BAF55-4344-467E-8DE9-19ECFAAB8419Q39080408-0BF06176-8C34-4BB8-96D1-7F1D1F5838E9Q39201211-629881B9-F686-4130-8CE5-B36592EBE182Q39558472-0FFD77EA-217D-4C82-AE3E-289F5B7F1EEDQ41441753-6F6DE5E5-F0DC-4575-A94F-A0B9D01F6681Q43489162-506267A0-3AD8-4CE6-A88D-F980D5753AF1Q46588877-ABB9CC76-1615-4136-8637-D0D3EEB3106BQ51062025-449FC7E9-FD41-4385-8E73-581BA4448CBD
P2860
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
@en
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
@nl
type
label
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
@en
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
@nl
prefLabel
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
@en
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
@nl
P2093
P2860
P356
P1476
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
@en
P2093
C Popadiuk
G M Yousef
J J E Doré
N M A White
P2860
P2888
P304
P356
10.1038/SJ.BJC.6605280
P407
P577
2009-10-01T00:00:00Z